Company intelligence / Profile preview

Diagnostic Biochips

Glen Burnie, Maryland, USAdiagnosticbiochips.com ↗

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

Diagnostic Biochips has developed and commercialized advanced neural probes and cloud-based software that enable high-fidelity recording of brain activity. Their technology is widely used by leading academic, government, and commercial organizations worldwide to advance neuroscience research. No clinical trial results apply as the company does not develop therapeutics but provides enabling technology for neuroscience discovery.

Modalities: DeviceBiosensor
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Diagnostic Biochips.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagnostic Biochips.

Explore the full profile